Roland Wehr

Title: Roland Wehr: Innovator in Pharmaceutical Chemistry

Introduction

Roland Wehr is a notable inventor based in Goettingen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical applications. His work focuses on innovative solutions for treating neoplastic and infectious diseases.

Latest Patents

Roland Wehr holds a patent for "Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases." This invention relates to bicyclic tetrahydrothiazepine of formula (I), wherein R to R, X, X, and R have the meanings as indicated in the description and claims. The patent also encompasses pharmaceutical compositions comprising such compounds and their use as medicaments, especially in methods for the treatment or prevention of neoplastic and/or infectious diseases and in vitro methods. He has 1 patent to his name.

Career Highlights

Throughout his career, Roland Wehr has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Apeiron Biologics AG and Evotec SE. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Roland Wehr has collaborated with several professionals in his field, including Monika Ermann and Guenther Lametschwandtner. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Roland Wehr's contributions to pharmaceutical chemistry, particularly through his patent on bicyclic tetrahydrothiazepine derivatives, highlight his role as an innovator in the treatment of serious diseases. His work continues to impact the medical field positively.